About NuvoAir AB
NuvoAir AB is a digital healthcare company that integrates hardware, software, and data to enhance the management of respiratory and cardiopulmonary conditions. The company’s platform, NuvoAir Home, is designed to improve the lives of individuals suffering from conditions such as COPD, asthma, cystic fibrosis, IPF, ALS, and muscular dystrophy. It leverages connected devices, including the FDA-cleared Air Next spirometer and the Aos metered-dose inhaler sensor, alongside a patient-facing application, self-management resources, and care coordination services. This comprehensive approach facilitates real-time remote monitoring of lung function, inhaler adherence, and symptom tracking, providing actionable insights to both patients and their healthcare providers.
For physicians, NuvoAir’s AI-driven platform offers a robust solution for delivering proactive and continuous virtual-first specialty care. It supports data-driven clinical decision-making by providing objective measurements of lung health trends over time and identifying early signs of exacerbations. The platform aims to streamline practice operations, reduce urgent hospital visits and readmissions, and lower overall healthcare costs. By partnering with health plans, risk-bearing entities, and specialists, NuvoAir enables personalized care plans and improved patient outcomes within a value-based care framework, while also supporting decentralized clinical trials across various phases of drug development.
Focus Areas
Business Intelligence
| Key Investors | Industrifonden, Investment AB Spiltan, AlbionVC, Hikma Ventures |
| Partnerships | Novartis, Royal Brompton Hospital, Harvard Boston Children's Hospital, King's College Hospital in London, Regeneron, Privia Medical Group – Georgia, Cary Medical Management, Security Health Plan of Wisconsin Inc., Curana Health |
| Acquisitions | NuvoAir Clinical Trials business acquired by Strados Labs (March 2026) |
| Technology | AI-driven MSO and patient management technology platform, cloud-native, remote monitoring devices (Air Next spirometer, Aos metered-dose inhaler sensor), integrated dashboard, digital therapeutics software (Aria), virtual-first care model |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
NuvoAir stands out for physicians by offering a comprehensive, AI-driven, virtual-first cardiopulmonary care model that significantly enhances clinical decision-making through real-time, high-quality patient data from FDA-cleared devices. The platform reduces administrative burden by automating workflows, allowing physicians to focus more on patient care. Proven outcomes, including reductions in hospitalizations, hospital days, and readmissions for COPD patients, demonstrate its effectiveness. For clinical trials, NuvoAir's decentralized approach streamlines operations and improves patient engagement. The integrated dashboard provides a holistic view of patient health, enabling proactive interventions and supporting success in value-based care models.
NuvoAir's platform is designed for seamless integration, collecting data from various connected devices and databases. It integrates with Electronic Medical Records (EMRs), claims data, and health information exchanges to create a comprehensive patient profile. NuvoAir also actively partners with health plans, risk-bearing entities, Contract Research Organizations (CROs), and pharmaceutical companies. Notable collaborations include ArtiQ for AI-based spirometry over-reading and Signify Health for in-home COPD diagnostic programs. NuvoAir Medical is also part of the Privia Health network.
What the Web Says
NuvoAir AB is a company that offers a smart spirometer, the Air Next, and a companion app for remote monitoring of respiratory conditions like asthma and COPD. The product is FDA-cleared and compliant with ATS/ERS 2019 standards, providing accurate lung function measurements and real-time coaching for patients. The company also emphasizes its use of AI to enhance patient care and operational efficiency in healthcare services. While product reviews are generally positive, employer reviews are mixed, with some highlighting a supportive work environment and others expressing concerns about work-life balance and management.
Overall: MixedStrengths
- Accurate and clinically validated smart spirometer (Air Next) for home use.
- Companion app provides real-time coaching and feedback, improving test quality.
- Disposable turbines ensure hygiene and eliminate cleaning.
- Effective for remote patient monitoring, reducing hospitalizations and improving quality of life for COPD patients.
- Integrates with clinical RPM and telehealth platforms.
- Positive work culture with empathetic and hardworking teams (according to some employee reviews).
Limitations
- Some employee reviews indicate poor work-life balance, pay, benefits, job security, and management.
- The Air Next device requires a Bluetooth connection to the app to operate, as it has no screen for manual use.
- One Reddit user expressed confusion about the specifics of NuvoAir's at-home monitoring service for COPD.
- One employee review described the company as 'terrible' and preying on the elderly population.
- The company is a startup, which can mean a lot to handle for new graduates.
Based on reviews from: MedGrade, AI in Healthcare: The Silent Revolution Reshaping NuvoAir, NuvoAir Respiratory Platform Shows Promise for Long-Term Remote Monitoring of Asthma, Healthcare Discovery AI, BioWorld, Indeed, Apple App Store, NuvoAir Medical, Reddit
Last updated: 2026-07-19
Videos
News, demos, and interviews about NuvoAir AB.
Videos load interactively. If none appear, search YouTube for NuvoAir AB →
Press & Coverage
Investors
Who's funded NuvoAir AB.
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]